[1]侯海军,崔植芳.三三汤与氨溴索口服液联合治疗支气管炎临床疗效及安全性观察[J].西部中医药,2022,35(03):108-111.[doi:10.12174/j.issn.2096-9600.2022.03.24]
 HOU Haijun,CUI Zhifang.Observation on the Safety and Clinical Effects of Sansan Decoction and Ambroxol Oral Liquid in the Treatment of Bronchitis[J].Western Journal of Traditional Chinese Medicine,2022,35(03):108-111.[doi:10.12174/j.issn.2096-9600.2022.03.24]
点击复制

三三汤与氨溴索口服液联合治疗支气管炎临床疗效及安全性观察
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年03期
页码:
108-111
栏目:
衷中参西
出版日期:
2022-03-15

文章信息/Info

Title:
Observation on the Safety and Clinical Effects of Sansan Decoction and Ambroxol Oral Liquid in the Treatment of Bronchitis
作者:
侯海军 崔植芳
东直门医院通州院区呼吸科,北京 101100
Author(s):
HOU Haijun CUI Zhifang
Department of Respiratory Medicine, Tongzhou Branch, Dongzhimen Hospital, Beijing 101100, China
关键词:
支气管炎安全性临床疗效氨溴索口服液三三汤
Keywords:
bronchitissafetyclinical effectsambroxol oral liquiddecoction
分类号:
R562
DOI:
10.12174/j.issn.2096-9600.2022.03.24
文献标志码:
B
摘要:
目的观察三三汤联合氨溴索口服液治疗支气管炎的临床疗效和安全性。 方法将支气管炎患者120例随机分为对照组和联合组各60例,对照组口服氨溴索口服液治疗,联合组患者采用三三汤联合氨溴索口服液治疗。观察两组患者临床疗效、临床症状缓解时间、血清炎性因子水平变化以及并发症的发生情况。 结果联合组总有效率为91.67%,高于对照组的68.33%;治疗后联合组患者咳嗽、咽痛与发热缓解时间及啰音消失时间短于对照组(P<0.05);治疗后联合组患者血清炎性因子γ-干扰素(interferon γ,IFN-γ)、白细胞介素8(interleukin,IL-8)和C反应蛋白(C reaction protein,CRP)含量低于对照组(P<0.05);治疗后联合组患者并发症发生率为10.00%,低于对照组的38.33%(P<0.05)。 结论三三汤联合氨溴索口服液可以快速缓解支气管炎患者临床症状,降低血清炎性因子水平,安全性较高。
Abstract:
ObjectiveTo observe clinical effects and the safety of Sansan decoction and ambroxol oral liquid in the treatment of bronchitis. MethodsAll 120 patients were randomized into the control group and the combination group, with 60 cases in each group, the control group was given ambroxol oral liquid, and the combination group adopted Sansan decoction and ambroxol oral liquid. To observe clinical effects, the remission time of clinical symptoms, the levels of serum inflammatory factors and the incidence of the complications between both groups. ResultsTotal effective rate of the combination group was 91.67%, higher than 68.33% of the control group; after treating, the combination group was shorter than the control group in the remission time of cough, sore throat and fever, the disappearing time of rale (P<0.05); after treating, the combination group was shorter than the control group in the contents of IFN-γ, IL-8 and CRP (P<0.05); after treating, the incidence of the complications of the combination group was 10.00%, lower than 38.33% of the control group (P<0.05). ConclusionSansan decoction and ambroxol oral liquid could rapidly alleviate clinical symptoms of the patients, lower the levels of serum inflammatory factors with higher safety.

相似文献/References:

[1]蒋英蓝,曾敬怀△,李荣,等.我院41例中药注射液不良反应及相关性分析[J].西部中医药,2013,26(01):68.
 JIANG Yinglan,ZENG Jinghuai,LI Rong,et al.Analysis on 41 Cases of Adverse Reactions of TCM Injections and The Related Factors[J].Western Journal of Traditional Chinese Medicine,2013,26(03):68.
[2]刘康乐.中西药物联用治疗小儿急性支气管炎86例[J].西部中医药,2013,26(08):90.
 LIU Kangle.Clinical Observation on Treating 86 Cases of Children Suffering from Acute Bronchitis with Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(03):90.
[3]雷琰,贾媛媛.中西医结合治疗慢性支气管炎58例疗效观察[J].西部中医药,2013,26(09):80.
 LEI Yan,JIA Yuanyuan.Clinical Observation on Treatment for 58 Cases of Chronic Bronchitis with Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(03):80.
[4]肖正国,刘效栓,李喜香,等.玉红膏治疗皮肤溃疡有效性的Meta分析*[J].西部中医药,2013,26(11):71.
 XIAO Zhengguo,LIU Xiaoshuan,LI Xixiang,et al.Meta Analysis on the Effectiveness of YuHong Ointment in Treating Skin Ulcer[J].Western Journal of Traditional Chinese Medicine,2013,26(03):71.
[5]王盛强.辨证论治慢性心力衰竭临床观察[J].西部中医药,2014,27(06):78.
 WANG Shengqiang.On Treating Chronic Heart Failure by Syndrome Differentiation and Treatment[J].Western Journal of Traditional Chinese Medicine,2014,27(03):78.
[6]戴玮.红外止咳贴辅助治疗老年患者喘息性支气管炎32例[J].西部中医药,2014,27(12):98.
[7]杨维建,张超,李娟,等.伤科洁肤液的相关药理学实验研究[J].西部中医药,2015,28(10):25.
[8]王 洋,韩玲爱,王永兴,等.黄龙咳喘胶囊治疗慢性支气管炎急性发作期(肺肾气虚、痰热郁肺证)的有效性和安全性[J].西部中医药,2015,28(11):6.
[9]章婷婷,赵 亚,王念宏△.艾烟安全性研究概述[J].西部中医药,2015,28(12):136.
[10]刘树明,胡志平,刘豪,等.药学干预在中药注射剂合理使用中的作用[J].西部中医药,2018,31(02):79.
 LIU Shuming,HU Zhiping,LIU Hao,et al.The Function of Pharmaceutical Intervention in Rational Use of Traditional Chinese Medicine Injection[J].Western Journal of Traditional Chinese Medicine,2018,31(03):79.

备注/Memo

备注/Memo:
侯海军(1980—),男,主治医师。研究方向:肺病的中医诊治。首都医学发展科研基金(2017-8714)。
更新日期/Last Update: 2022-06-24